Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injecti... Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2 | 4.97760079642 | 40.18 | 43.42 | 37.46 | 441553 | 40.71113053 | CS |
4 | 1.56 | 3.84047267356 | 40.62 | 47.3 | 37.46 | 688073 | 42.48381944 | CS |
12 | 8.3 | 24.4982290437 | 33.88 | 47.3 | 33.69 | 519932 | 39.69014651 | CS |
26 | -5.28 | -11.1251580278 | 47.46 | 48.51 | 32.65 | 653742 | 39.17341649 | CS |
52 | 31.56 | 297.175141243 | 10.62 | 50.78 | 9.24 | 814359 | 34.07741249 | CS |
156 | 25.27 | 149.438202247 | 16.91 | 50.78 | 5.2 | 485243 | 24.66210605 | CS |
260 | 30.77 | 269.67572305 | 11.41 | 50.78 | 5.2 | 432662 | 24.55626284 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.